339 results
Search Results
2. Correction: Suleman et al. Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation. Vaccines 2021, 9 , 1210
- Author
-
Suleman, Muhammad, Tahir ul Qamar, Muhammad, Kiran, Rasool, Samreen, Rasool, Aneela, Albutti, Aqel, Alsowayeh, Noorah, Alwashmi, Ameen S. S., Aljasir, Mohammad Abdullah, Ahmad, Sajjad, Hussain, Zahid, Rizwan, Muhammad, Ali, Syed Shujait, Khan, Abbas, and Wei, Dong-Qing
- Subjects
TICK-borne encephalitis viruses ,B cells ,MOLECULAR docking ,DYNAMIC simulation ,IMMUNE response - Abstract
This correction notice addresses an error in a published paper titled "Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation." The authors discovered that the abstract of the paper was an exact duplicate of the abstract from a previously published paper by the same authors. This mistake occurred due to a wrong version being mistakenly uploaded during the publication process. The corrected abstract provides information about the design of a potential antigenic and non-allergenic multi-epitope subunit vaccine against TBEV, which shows promise for both in vitro and in vivo analyses. The authors state that this error does not affect the scientific conclusions of the paper. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
3. Correction: Chakraborty et al. Bromelain a Potential Bioactive Compound: A Comprehensive Overview from a Pharmacological Perspective. Life 2021, 11 , 317.
- Author
-
Chakraborty, Arka Jyoti, Mitra, Saikat, Tallei, Trina E., Tareq, Abu Montakim, Nainu, Firzan, Cicia, Donatella, Dhama, Kuldeep, Emran, Talha Bin, Simal-Gandara, Jesus, and Capasso, Raffaele
- Subjects
BROMELIN ,B cells ,BIOACTIVE compounds ,OVALBUMINS ,BERBERINE ,REPERFUSION ,APIS cerana - Abstract
This document is a correction notice for a paper on the potential bioactive compound bromelain. The authors have identified errors in one section of the paper and provide revised references. The corrected table includes therapeutic studies of bromelain based on experimental studies. The document also includes a compilation of various scientific studies and articles related to the use of bromelain for various medical purposes. The studies explore the potential benefits of bromelain in treating conditions such as cancer, inflammation, thrombosis, and pain. The document provides a comprehensive overview of the scientific research on bromelain and its potential applications in medicine. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
4. Enhanced mitochondrial function in B cells from elderly type-2 diabetes mellitus patients supports intrinsic inflammation.
- Author
-
Frasca, Daniela and Bueno, Valquiria
- Subjects
MITOCHONDRIAL physiology ,IN vitro studies ,FLOW cytometry ,PEARSON correlation (Statistics) ,RESEARCH funding ,BODY mass index ,ACADEMIC medical centers ,T-test (Statistics) ,INFLUENZA vaccines ,VACCINE effectiveness ,POLYMERASE chain reaction ,ENZYME-linked immunosorbent assay ,AGE distribution ,DESCRIPTIVE statistics ,HEMAGGLUTINATION tests ,METABOLITES ,MESSENGER RNA ,TYPE 2 diabetes ,AMYLOID ,STATISTICS ,INFLAMMATION ,CYTOKINES ,FACTOR analysis ,DATA analysis software ,B cells ,OBESITY ,C-reactive protein ,TUMOR necrosis factors ,INTERLEUKINS ,BIOMARKERS - Abstract
In this paper, we measured B cell function in elderly healthy individuals (E
H ) and in elderly patients with Type-2 Diabetes Mellitus (T2DM, ET2DM ), which are treatment-naive, as compared to healthy young (YH ) individuals. Results show a higher serum inflammatory status of elderly versus young individuals, and especially of ET2DM versus EH . This status is associated with a reduced response to the seasonal influenza vaccine and with increased frequencies of the circulating pro-inflammatory B cell subset called Double Negative (DN) B cells. B cells from ET2DM patients are not only more inflammatory but also hyper-metabolic as compared to those from EH controls. The results herein are to our knowledge the first to show that T2DM superimposed on aging further increases systemic and B cell intrinsic inflammation, as well as dysfunctional humoral immunity. Our findings confirm and extend our previously published findings showing that inflammatory B cells are metabolically supported. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
5. Dynamics of Activation and Regulation of the Immune Response to Attack by Viral Pathogens Using Mathematical Modeling.
- Author
-
Cuesta-Herrera, Ledyz, Pastenes, Luis, Arencibia, Ariel D., Córdova-Lepe, Fernando, and Montoya, Cristhian
- Subjects
REGULATORY T cells ,IMMUNOREGULATION ,CYTOTOXIC T cells ,B cells ,SARS-CoV-2 ,T cells ,HOMEOSTASIS - Abstract
In this paper, a mathematical model is developed to simulate the activation of regulatory T lymphocytes dynamics. The model considers the adaptive immune response and consists of epithelial cells, infected cells, free virus particles, helper and cytotoxic T lymphocytes, B lymphocytes, and regulatory T lymphocytes. A mathematical analysis was carried out to discuss the conditions of existence and stability of equilibrium solutions in terms of the basic reproductive number. In addition, the definitions and properties necessary to preserve the positivity and stability of the model are shown. The precision of these mathematical models can be affected by numerous sources of uncertainty, partly due to the balance between the complexity of the model and its predictive capacity to depict the biological process accurately. Nevertheless, these models can provide remarkably perspectives on the dynamics of infection and assist in identification specific immunological traits that improve our comprehension of immune mechanisms. The theoretical results are validated by numerical simulations using data reported in the literature. The construction, analysis, and simulation of the developed models demonstrate that the increased induced regulatory T lymphocytes effectively suppress the inflammatory response in contrast to similar cells at lower contents, playing a key role in maintaining self-tolerance and immune homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. The challenges and breakthroughs in the development of diagnostic monoclonal antibodies.
- Author
-
Wang, Jing, Song, Qitao, Yang, Tao, Li, Yuanli, Zhang, Lihua, Li, Jiayan, Liu, Feifei, Lin, Yanyin, Xu, Xiaoxia, Heng, Yu, Xu, Lulai, Zhang, Shun, Zhou, Jiahui, Liu, Yunbo, Kong, Lingyuan, Tang, Dingbin, Ji, Chengdong, Tan, Bing, Liao, Pu, and Pan, Nengke
- Subjects
MONOCLONAL antibodies ,B cells ,ARTIFICIAL intelligence ,SYNTHETIC antibodies ,ANTIBODY formation ,TECHNOLOGICAL innovations ,DISPLAY systems ,MACHINE learning - Abstract
Over the past century, the field of antibody discovery has undergone significant evolution, excluding the current exploration stage of artificial intelligence‐based antibody generation and the often overlooked non‐animal sourced antibody discovery, which typically requires mature in vitro affinity and the selection of high‐quality antigen formulations. This journey has traversed various stages, from methods involving serum‐based antibody acquisition, the isolation of B cells capable of perpetual antibody production through hybridoma technology, to the in‐depth exploration of genetic material using the phage display system, and the current stage involving diverse single B cell screening techniques. Additionally, the emergence of machine learning has brought impressive scientific and technological breakthroughs across research domains, proving to be a powerful application in the field of antibody discovery. However, each technique comes with its limitations, such as variability and control challenges in serum‐based acquisition, lengthy and difficult hybridoma‐derived antibody development, potential limitations in sequence and epitope diversity due to immunization biases in phage display techniques, and costly single B cell screening. Protein mass spectrometry sequencing, with shorter acquisition time and lower costs, is seen as a shortcut by diagnostic companies, impacting traditional antibody development. In diagnostic antibody development, methodological differences in downstream assays and the impact of constant regions outside the Fv core are often neglected. This paper deeply analyzes challenges, proposing innovative strategies for the next generation of diagnostic antibody development. Aimed at moving closer to the gold standard of antibody discovery, these strategies enhance the competitiveness of diagnostic reagent products. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Anti-Idiotypic mRNA Vaccine to Treat Autoimmune Disorders.
- Author
-
Niazi, Sarfaraz K.
- Subjects
AUTOIMMUNE diseases ,MESSENGER RNA ,AUTOANTIBODIES ,B cells ,T cells - Abstract
The 80+ existing autoimmune disorders (ADs) affect billions with little prevention or treatment options, except for temporary symptomatic management, leading to enormous human suffering and a monumental financial burden. The autoantibodies formed in most ADs have been identified, allowing the development of novel anti-idiotypic antibodies to mute the autoantibodies using vaccines. Nucleoside vaccines have been successfully tested as antigen-specific immunotherapies (ASI), with mRNA technology offering multi-epitope targeting to mute multiple autoantibodies. This paper proposes using mRNA technology to produce anti-idiotypic antibodies with broad effectiveness in preventing and treating them. This paper delves into the state-of-the-art mRNA design strategies used to develop novel ASIs by selecting appropriate T cell and B cell epitopes to generate anti-idiotypic antibodies. The low cost and fast development of mRNA vaccines make this technology the most affordable for the global control of ADs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Method for B Cell Receptor Enrichment in Malignant B Cells.
- Author
-
Bhattacharyya, Puja, Christopherson, Richard I., Skarratt, Kristen K., and Fuller, Stephen J.
- Subjects
PROTEIN analysis ,RESEARCH funding ,IMMUNE system ,ANTIGENS ,MASS spectrometry ,PROTEOMICS ,B cells - Abstract
Simple Summary: The B cell receptor (BCR) is a membrane-bound protein complex that is required for the normal development of B cells. BCR signalling is also involved in the pathogenesis of B cell cancers. While there is substantial literature on genomic analyses of the BCR, there are limited proteomic studies of receptor structure and its interactions with neighbouring proteins. This is partly due to the location of the BCR in the surface-membrane lipid environment that has limited the ability to enrich the complex for proteomic analysis. Here, we report an enrichment technique that can be used for mass spectrometry analyses of the BCR from live B cells. B cells are central to the adaptive immune response and provide long-lasting immunity after infection. B cell activation is mediated by the surface membrane-bound B cell receptor (BCR) following recognition of a specific antigen. The BCR has been challenging to analyse using mass spectrometry (MS) due to the difficulty of isolating and enriching this membrane-bound protein complex. There are approximately 120,000 BCRs on the B cell surface; however, depending on the B cell activation state, there may be hundreds-of-millions to billions of proteins in a B cell. Consequently, advanced proteomic techniques such as MS workflows that use purified proteins to yield structural and protein-interaction information have not been published for the BCR complex. This paper describes a method for enriching the BCR complex that is MS-compatible. The method involves a Protein G pull down on agarose beads using an intermediary antibody to each of the BCR complex subcomponents (CD79a, CD79b, and membrane immunoglobulin). The enrichment process is shown to pull down the entire BCR complex and has the advantage of being readily compatible with further proteomic study including MS analysis. Using intermediary antibodies has the potential to enrich all isotypes of the BCR, unlike previous methods described in the literature that use protein G-coated beads to directly pull down the membrane IgG (mIgG) but cannot be used for other mIg isotypes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. EXPERIMENTAL PLAN BASED ON THE RANDOMIZED COMPLETE BLOCK METHOD FOR THE DEVELOPMENT OF FLEXIBLE MATERIALS FOR ELECTROMAGNETIC ATTENUATION.
- Author
-
Raluca Maria, AILENI, Cornel Adrian, MARIN, and Laurentiu Cristian, DINCA
- Subjects
ELECTROMAGNETIC waves ,ELECTROMAGNETIC shielding ,KILLER cells ,ELECTROMAGNETIC devices ,B cells - Abstract
The negative effects of continuous exposure to electromagnetic waves know a continuous growth on the last years because of new developments in electronics and mobile communication applications in different fields (medical, smart devices for IoT applications). There are some researches concluding that exposure to electromagnetic fields could affect the cells (PMBCs, T lymphocytes, B lymphocytes, NK cells and macrophages) of the immune system including cell proportion, cell cycle, apoptosis, destruction activity and cytokine content. Considering the negative effect of electromagnetic inference, it is necessary to develop advanced materials to attenuate electromagnetic waves to protect electronic equipment and humans. In this context, this paper presents an experimental plan based on completely randomized blocks (RCBD) for obtaining adequate textile coating for electromagnetic shielding applications taking into account the design of electromagnetic shielding devices should include the modelling of the attenuation phenomenon of electromagnetic waves using Schelkunoff and Calculation theories. The proposed experimental plan consists of experiments distributed in blocks, each block corresponding to the technology used. For each experimental block, the factors specific to the technology used (independent variables such as the metals used (Ni, Cu, graphite, Fe3O4, Ag, Zn), mass (M), air permeability (Pa), thickness (d)) that could influence the response variable (electrical resistance (Rs)) have been taken into consideration. [ABSTRACT FROM AUTHOR]
- Published
- 2024
10. The Lung in Rheumatoid Arthritis—Friend or Enemy?
- Author
-
Anton, Maria-Luciana, Cardoneanu, Anca, Burlui, Alexandra Maria, Mihai, Ioana Ruxandra, Richter, Patricia, Bratoiu, Ioana, Macovei, Luana Andreea, and Rezus, Elena
- Subjects
LUNGS ,RHEUMATOID arthritis ,CHEMOKINE receptors ,INTERSTITIAL lung diseases ,SYNOVIAL membranes ,B cells ,IMMUNE system - Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune condition frequently found in rheumatological patients that sometimes raises diagnosis and management problems. The pathogenesis of the disease is complex and involves the activation of many cells and intracellular signaling pathways, ultimately leading to the activation of the innate and acquired immune system and producing extensive tissue damage. Along with joint involvement, RA can have numerous extra-articular manifestations (EAMs), among which lung damage, especially interstitial lung disease (ILD), negatively influences the evolution and survival of these patients. Although there are more and more RA-ILD cases, the pathogenesis is incompletely understood. In terms of genetic predisposition, external environmental factors act and subsequently determine the activation of immune system cells such as macrophages, neutrophils, B and T lymphocytes, fibroblasts, and dendritic cells. These, in turn, show the ability to secrete molecules with a proinflammatory role (cytokines, chemokines, growth factors) that will produce important visceral injuries, including pulmonary changes. Currently, there is new evidence that supports the initiation of the systemic immune response at the level of pulmonary mucosa where the citrullination process occurs, whereby the autoantibodies subsequently migrate from the lung to the synovial membrane. The aim of this paper is to provide current data regarding the pathogenesis of RA-associated ILD, starting from environmental triggers and reaching the cellular, humoral, and molecular changes involved in the onset of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. The Functional Mechanism of BP9 in Promoting B Cell Differentiation and Inducing Antigen Presentation.
- Author
-
Hu, Jianing, Zhang, Ze, Cai, Jiaxi, Hao, Shanshan, Li, Chenfei, and Feng, Xiuli
- Subjects
B cell differentiation ,ANTIGEN presentation ,PLASMA cells ,B cells ,CELL differentiation - Abstract
The Bursa of Fabricius, an avian unique humoral immune organ, is instrumental to B cell development. Bursal-derived peptide BP9 fosters B-cell development and formation. Yet, the exact mechanism wherein BP9 impacts B cell differentiation and antigenic presentation remains undefined. In this paper, B cell activation and differentiation in the spleen cells from mice immunized with the AIV vaccine and BP9 were detected following flow cytometry (FCM) analysis. Furthermore, the molecular mechanism of BP9 in B cell differentiation in vivo was investigated with RNA sequencing technology. To verify the potential functional mechanism of BP9 in the antigenic presentation process, the transcriptome molecular basis of chicken macrophages stimulated by BP9 was measured via high-throughput sequencing technology. The results proved that when given in experimental dosages, BP9 notably accelerated total B cells, and enhanced B-cell differentiation and plasma cell production. The gene expression profiles of B cells from mice immunized with 0.01 mg/mL BP9 and AIV vaccine disclosed that 0.01 mg/mL BP9 initiated the enrichment of several biological functions and significantly stimulated key B-cell pathways in immunized mice. Crucially, a total of 4093 differentially expressed genes were identified in B cells with BP9 stimulation, including 943 upregulated genes and 3150 downregulated genes. Additionally, BP9 induced various cytokine productions in the chicken macrophage HD11 cells and activated 9 upregulated and 20 downregulated differential miRNAs, which were involved in various signal and biological processes. Furthermore, BP9 stimulated the activation of multiple transcription factors in HD11 cells, which was related to antigen presentation processes. In summary, these results suggested that BP9 might promote B cell differentiation and induce antigen presentation, which might provide the valuable insights into the mechanism of B cell differentiation upon bursal-derived immunomodulating peptide stimulation and provide a solid experimental groundwork for enhancing vaccine-induced immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Cadmium Exposure: Mechanisms and Pathways of Toxicity and Implications for Human Health.
- Author
-
Qu, Fei and Zheng, Weiwei
- Subjects
MITOGEN-activated protein kinases ,CADMIUM ,EPIGENOMICS ,POISONS ,CELL anatomy ,CELL communication ,B cells ,HISTONES - Abstract
Cadmium (Cd), a prevalent environmental contaminant, exerts widespread toxic effects on human health through various biochemical and molecular mechanisms. This review encapsulates the primary pathways through which Cd inflicts damage, including oxidative stress induction, disruption of Ca
2+ signaling, interference with cellular signaling pathways, and epigenetic modifications. By detailing the absorption, distribution, metabolism, and excretion (ADME) of Cd, alongside its interactions with cellular components such as mitochondria and DNA, this paper highlights the extensive damage caused by Cd2+ at the cellular and tissue levels. The role of Cd in inducing oxidative stress—a pivotal mechanism behind its toxicity—is discussed with emphasis on how it disrupts the balance between oxidants and antioxidants, leading to cellular damage and apoptosis. Additionally, the review covers Cd's impact on signaling pathways like Mitogen-Activated Protein Kinase (MAPK), Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB), and Tumor Protein 53 (p53) pathways, illustrating how its interference with these pathways contributes to pathological conditions and carcinogenesis. The epigenetic effects of Cd, including DNA methylation and histone modifications, are also explored to explain its long-term impact on gene expression and disease manifestation. This comprehensive analysis not only elucidates the mechanisms of Cd toxicity but also underscores the critical need for enhanced strategies to mitigate its public health implications. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. Unravelling B cell heterogeneity: insights into flow cytometrygated B cells from single-cell multi-omics data.
- Author
-
Pernes, Jane I., Alsayah, Atheer, Tucci, Felicia, and Bashford-Rogers, Rachael J. M.
- Subjects
B cells ,MULTIOMICS ,CELL populations ,CELL physiology ,HETEROGENEITY - Abstract
Introduction: B cells play a pivotal role in adaptive immunity which has been extensively characterised primarily via flow cytometry-based gating strategies. This study addresses the discrepancies between flow cytometry-defined B cell subsets and their high-confidence molecular signatures using single-cell multiomics approaches. Methods: By analysing multi-omics single-cell data from healthy individuals and patients across diseases, we characterised the level and nature of cellular contamination within standard flow cytometric-based gating, resolved some of the ambiguities in the literature surrounding unconventional B cell subsets, and demonstrated the variable effects of flow cytometric-based gating cellular heterogeneity across diseases. Results: We showed that flow cytometric-defined B cell populations are heterogenous, and the composition varies significantly between disease states thus affecting the implications of functional studies performed on these populations. Importantly, this paper draws caution on findings about B cell selection and function of flow cytometric-sorted populations, and their roles in disease. As a solution, we developed a simple tool to identify additional markers that can be used to increase the purity of flow-cytometric gated immune cell populations based on multi-omics data (AlliGateR). Here, we demonstrate that additional non-linear CD20, CD21 and CD24 gating can increase the purity of both naïve and memory populations. Discussion: These findings underscore the need to reconsider B cell subset definitions within the literature and propose leveraging single-cell multi-omics data for refined characterisation. We show that single-cell multi-omics technologies represent a powerful tool to bridge the gap between surface marker-based annotations and the intricate molecular characteristics of B cell subsets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Role of germinal center and CD39highCD73+ B cells in the age-related tonsillar involution.
- Author
-
Pastor, Rocío, Puyssegur, Juliana, de la Guardia, M. Paula, Varón, Lindybeth Sarmiento, Beccaglia, Gladys, Spada, Nicolás, de Lima, Andrea Paes, Collado, M. Soledad, Blanco, Andrés, Scetti, Isabel Aspe, Arabolaza, M. Elena, Paoli, Bibiana, Chirdo, Fernando, and Arana, Eloísa
- Subjects
B cells ,GERMINAL centers ,IMMUNOLOGIC memory ,T helper cells ,MUCOUS membranes - Abstract
Background: The tonsils operate as a protection ring of mucosa at the gates of the upper aero-digestive tract. They show similarities with lymph nodes and participate as inductive organs of systemic and mucosal immunity. Based on the reduction of their size since puberty, they are thought to experience involution in adulthood. In this context, we have used tonsillar mononuclear cells (TMC) isolated from patients at different stages of life, to study the effect of ageing and the concomitant persistent inflammation on these immune cells. Results: We found an age-dependent reduction in the proportion of germinal center B cell population (B
GC ) and its T cell counterpart (T follicular helper germinal center cells, TfhGC ). Also, we demonstrated an increment in the percentage of local memory B cells and mantle zone T follicular helper cells (mTfh). Furthermore, younger tonsils rendered higher proportion of proliferative immune cells within the freshly isolated TMC fraction than those from older ones. We demonstrated the accumulation of a B cell subset (CD20+ CD39high CD73+ cells) metabolically adapted to catabolize adenosine triphosphate (ATP) as patients get older. To finish, tonsillar B cells from patients at different ages did not show differences in their proliferative response to stimulation ex vivo, in bulk TMC cultures. Conclusions: This paper sheds light on the changing aspects of the immune cellular landscape, over the course of time and constant exposure, at the entrance of the respiratory and digestive systems. Our findings support the notion that there is a re-modelling of the immune functionality of the excised tonsils over time. They are indicative of a transition from an effector type of immune response, typically oriented to reduce pathogen burden early in life, to the development of an immunosuppressive microenvironment at later stages, when tissue damage control gets critical provided the time passed under immune attack. Noteworthy, when isolated from such histologic microenvironment, older tonsillar B cells seem to level their proliferation capacity with the younger ones. Understanding these features will not only contribute to comprehend the differences in susceptibility to pathogens among children and adults but would also impact on vaccine developments intended to target these relevant mucosal sites. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
15. B cells in head and neck squamous cell carcinoma: current opinion and novel therapy.
- Author
-
Guo, Xinyue, Xu, Licheng, Nie, Luan, Zhang, Chenyu, Liu, Yaohui, Zhao, Rui, Cao, Jing, Tian, Linli, and Liu, Ming
- Subjects
B cells ,SQUAMOUS cell carcinoma ,IMMUNE checkpoint inhibitors ,T cells ,TUMOR microenvironment ,RADIOTHERAPY - Abstract
Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumour. Despite advancements in surgery, radiotherapy and chemotherapy, which have improved the prognosis of most patients, a subset of patients with poor prognoses still exist due to loss of surgical opportunities, postoperative recurrence, and metastasis, among other reasons. The tumour microenvironment (TME) is a complex organization composed of tumour, stromal, and endothelial cells. Communication and interaction between tumours and immune cells within the TME are increasingly being recognized as pivotal in inhibiting or promoting tumour development. Previous studies on T cells in the TME of HNSCC have yielded novel therapeutic possibilities. However, the function of B cells, another adaptive immune cell type, in the TME of HNSCC patients has yet to be determined. Recent studies have revealed various distinct subtypes of B cells and tertiary lymphoid structures (TLSs) in the TME of HNSCC patients, which are believed to impact the efficacy of immune checkpoint inhibitors (ICIs). Therefore, this paper focuses on B cells in the TME to explore potential directions for future immunotherapy for HNSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The Roles of Various Immune Cell Populations in Immune Response against Helminths.
- Author
-
Lekki-Jóźwiak, Janina and Bąska, Piotr
- Subjects
CELL populations ,IMMUNE response ,B cells ,INNATE lymphoid cells ,HELMINTHS ,HELMINTHIASIS ,KNOWLEDGE gap theory - Abstract
Helminths are multicellular parasites that are a substantial problem for both human and veterinary medicine. According to estimates, 1.5 billion people suffer from their infection, resulting in decreased life quality and burdens for healthcare systems. On the other hand, these infections may alleviate autoimmune diseases and allergy symptoms. The immune system is programmed to combat infections; nevertheless, its effector mechanisms may result in immunopathologies and exacerbate clinical symptoms. This review summarizes the role of the immune response against worms, with an emphasis on the Th
2 response, which is a hallmark of helminth infections. We characterize non-immune cells (enteric tuft cells—ETCs) responsible for detecting parasites, as well as the role of hematopoietic-derived cells (macrophages, basophils, eosinophils, neutrophils, innate lymphoid cells group 2—ILC2s, mast cells, T cells, and B cells) in initiating and sustaining the immune response, as well as the functions they play in granulomas. The aim of this paper is to review the existing knowledge regarding the immune response against helminths, to attempt to decipher the interactions between cells engaged in the response, and to indicate the gaps in the current knowledge. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
17. Understanding the role of B cells in CAR T-cell therapy in leukemia through a mathematical model.
- Author
-
Serrano, Sergio, Barrio, Roberto, Martínez-Rubio, Álvaro, Belmonte-Beitia, Juan, and Pérez-García, Víctor M.
- Subjects
- *
TREATMENT effectiveness , *CHIMERIC antigen receptors , *LYMPHOBLASTIC leukemia , *T cells , *ACUTE leukemia , *B cells - Abstract
Chimeric antigen receptor T (CAR T) cell therapy has been proven to be successful against a variety of leukemias and lymphomas. This paper undertakes an analytical and numerical study of a mathematical model describing the competition of CAR T, leukemia, tumor, and B cells. Considering its significance in sustaining anti-CD19 CAR T-cell stimulation, a B-cell source term is integrated into the model. Through stability and bifurcation analyses, the potential for tumor eradication, contingent on the continuous influx of B cells, has been revealed, showing a transcritical bifurcation at a critical B-cell input. Additionally, an almost heteroclinic cycle between equilibrium points is identified, providing a theoretical basis for understanding disease relapse. Analyzing the oscillatory behavior of the system, the time-dependent dynamics of CAR T cells and leukemic cells can be approximated, shedding light on the impact of initial tumor burden on therapeutic outcomes. In conclusion, the study provides insights into CAR T-cell therapy dynamics for acute lymphoblastic leukemias, offering a theoretical foundation for clinical observations and suggesting avenues for future immunotherapy modeling research. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Detection of HIV-1 DNA/RNA in Peripheral Blood, Bone Marrow and Femoral Head of Patients with Osteonecrosis of the Femoral Head [Letter].
- Author
-
Idrus, Hasta Handayani, Fitriana, and Adiningsih, Setyo
- Subjects
FEMUR head ,FEMUR ,HIV ,BONE marrow ,OSTEONECROSIS ,RNA ,B cells - Abstract
This document is a letter written by Hasta Handayani Idrus, Fitriana, and Setyo Adiningsih in response to a paper by Kang Peng Li et al on the detection of HIV-1 DNA/RNA in patients with osteonecrosis of the femoral head. The authors commend the study for providing new information on the profile of viral infection in the bone marrow and femur of people living with HIV. They highlight the importance of investigating impaired immune responses in osteonecrosis and the potential role of excessive corticosteroid therapy in inducing the condition. The authors also suggest further research on the bone marrow of chronically HIV-infected individuals who are not receiving antiretroviral therapy. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
19. Mime-seq 2.0: a method to sequence microRNAs from specific mouse cell types
- Author
-
Mandlbauer, Ariane, Sun, Qiong, Popitsch, Niko, Schwickert, Tanja, Spanova, Miroslava, Wang, Jingkui, Ameres, Stefan L, Busslinger, Meinrad, and Cochella, Luisa
- Published
- 2024
- Full Text
- View/download PDF
20. Editorial: Exploring the role of T helper cells in autoimmune disease.
- Author
-
Haghmorad, Dariush, Oksenych, Valentyn, and Huszthy, Peter C.
- Subjects
T helper cells ,AUTOIMMUNE diseases ,REGULATORY T cells ,AUTOIMMUNE thyroiditis ,SYNOVIAL fluid ,B cells - Abstract
This article explores the role of T helper cells in autoimmune diseases and the need for more effective treatment strategies. The authors specifically focus on autoreactive CD4+ T helper cells, particularly the T follicular helper subset, which promote the production of autoantibodies. They also discuss the imbalance between pathogenic peripheral T helper cells and tissue-resident Tregs in autoimmune diseases. The article highlights the importance of further research to develop targeted therapies for controlling autoimmune diseases. Additionally, the document provides a summary of various studies and reviews on the role of T helper cells in specific autoimmune diseases, aiming to contribute to the understanding of T cell involvement and potential therapeutic targets. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
21. Sequence, structure prediction, and epitope analysis of the polymorphic membrane protein family in Chlamydia trachomatis.
- Author
-
Cervantes, Patrick W., Segelke, Brent W., Lau, Edmond Y., Robinson, Beverly V., Abisoye-Ogunniyan, Abisola, Pal, Sukumar, de la Maza, Luis M., Coleman, Matthew A., and D'haeseleer, Patrik
- Subjects
CHLAMYDIA trachomatis ,MEMBRANE proteins ,PROTEIN structure prediction ,B cells ,CELL adhesion ,PROTEIN analysis - Abstract
The polymorphic membrane proteins (Pmps) are a family of autotransporters that play an important role in infection, adhesion and immunity in Chlamydia trachomatis. Here we show that the characteristic GGA(I,L,V) and FxxN tetrapeptide repeats fit into a larger repeat sequence, which correspond to the coils of a large beta-helical domain in high quality structure predictions. Analysis of the protein using structure prediction algorithms provided novel insight to the chlamydial Pmp family of proteins. While the tetrapeptide motifs themselves are predicted to play a structural role in folding and close stacking of the beta-helical backbone of the passenger domain, we found many of the interesting features of Pmps are localized to the side loops jutting out from the beta helix including protease cleavage, host cell adhesion, and B-cell epitopes; while T-cell epitopes are predominantly found in the beta-helix itself. This analysis more accurately defines the Pmp family of Chlamydia and may better inform rational vaccine design and functional studies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Traditional Chinese Medicine for Cancer Treatment.
- Author
-
Liu, Yangli, Fang, Cheng, Luo, Jiaojiao, Gong, Chenyuan, Wang, Lixin, and Zhu, Shiguo
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *CHINESE medicine , *VASCULAR endothelial growth factors , *TELOMERASE , *MACROPHAGES , *KILLER cells , *T cells , *CANCER patient medical care , *CELL proliferation , *APOPTOSIS , *MYELOID-derived suppressor cells , *METASTASIS , *CELL lines , *ENERGY metabolism , *TUMORS , *CARCINOGENESIS , *GENETIC mutation , *PATHOLOGIC neovascularization , *NATURAL immunity , *DENDRITIC cells , *B cells - Abstract
In recent years, due to advancements in medical conditions and the development of scientific research, the fundamental research of TCM antitumor treatments has progressed from the cellular level to the molecular and genetic levels. Previous studies have demonstrated the significant role of traditional Chinese medicine (TCM) in antitumor therapy through various mechanisms and pathways. Its mechanism of action is closely associated with cancer biology across different stages. This includes inhibiting tumor cell proliferation, blocking invasion and metastasis to surrounding tissues, inducing tumor cell apoptosis, inhibiting tumor angiogenesis, regulating immune function, maintaining genome stability, preventing mutation, and regulating cell energy metabolism. The use of TCM for eliciting antitumor effects not only has a good therapeutic effect and low side effects, it also provides a solid theoretical basis for clinical treatment and medication. This paper reviews the mechanism of the antitumor effects of TCM based on tumor characteristics. Through our review, we found that TCM not only directly inhibits tumors, but also enhances the body's immunity, thereby indirectly inducing an antitumor effect. This function aligns with the TCM theory of "strengthening the body's resistance to eliminate pathogenic factors". Furthermore, TCM will play a significant role in tumor treatment in clinical settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Potential Therapeutic Application and Mechanism of Action of Stem Cell-Derived Extracellular Vesicles (EVs) in Systemic Lupus Erythematosus (SLE).
- Author
-
Rajeev Kumar, Sushmitha, Sakthiswary, Rajalingham, and Lokanathan, Yogeswaran
- Subjects
SYSTEMIC lupus erythematosus ,EXTRACELLULAR vesicles ,REGULATORY T cells ,B cells ,AUTOIMMUNE diseases ,DISEASE progression ,CHILDBEARING age - Abstract
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that affects nearly 3.41 million people globally, with 90% of the cases affecting women of childbearing age. SLE is a complex disease due to the interplay of various immunological pathways and mechanisms. This scoping review aims to highlight the latest research findings on the therapeutic mechanisms of action of EVs in SLE. Relevant research articles were identified using the PRISMA framework from databases such as PubMed/MEDLINE (National Library of Medicine), Scopus (Elsevier), and Web of Science: Core Collection (Clarivate Analytics) from July 2023 to October 2023. Eleven studies met the inclusion criteria and thus were included in this scoping review. The findings showed that EVs have therapeutic effects on ameliorating the disease progression of SLE. EVs can reduce the pro-inflammatory cytokines and increase the anti-inflammatory cytokines. Moreover, EVs can increase the levels of regulatory T cells, thus reducing inflammation. EVs also have the potential to regulate B cells to alleviate SLE and reduce its adverse effects. The scoping review has successfully analysed the therapeutic potential in ameliorating the disease progression of SLE. The review also includes prospects to improve the effects of EVs further to increase the therapeutic effects on SLE. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Editorial: Pathogenic roles of T cells in autoimmunity.
- Author
-
Jinfang Xia, Jifeng Tang, Qiong Fu, and Jinpiao Lin
- Subjects
T cells ,AUTOIMMUNE diseases ,LEPTIN ,T cell receptors ,AUTOIMMUNITY ,REGULATORY T cells ,SJOGREN'S syndrome ,B cells - Abstract
This article, titled "Editorial: Pathogenic roles of T cells in autoimmunity," explores the role of T cells in autoimmune diseases. The immune system has mechanisms in place to prevent self-reactive T and B lymphocytes from causing autoimmune diseases, but these mechanisms are imperfect. Helper T cells, specifically CD4 T cells, play a crucial role in the development of autoimmune diseases. The article discusses the different subsets of helper T cells and their functions, as well as the potential for targeting pathogenic T cells in the treatment and prevention of autoimmune diseases. The research topic also includes papers on the pathogenic roles of T cells in specific autoimmune diseases such as vitiligo, idiopathic inflammatory myopathies, and primary Sjogren Syndrome. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
25. CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up.
- Author
-
Elmarasi, Mohamed, Elkonaissi, Islam, Elsabagh, Ahmed Adel, Elsayed, Engy, Elsayed, Abdelrahman, Elsayed, Basant, Elmakaty, Ibrahim, and Yassin, Mohamed
- Subjects
- *
CELLULAR therapy , *CHIMERIC antigen receptors , *HEMATOLOGIC malignancies , *CYTOKINE release syndrome , *T cells , *B cells - Abstract
• CAR-T therapy offers durable remissions in refractory hematological malignancies. • Meta-analyses show significant efficacy in various hematologic cancers. • CAR T-cell therapy improves quality of life for blood cancer patients. • Encouraging results in CD22-targeting CAR T-cell therapy for B-cell malignancies. • Long-term studies reveal durable remissions but also persistent adverse effects. Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a groundbreaking and highly promising approach for the management of cancer. This paper reviews the efficacy of CAR-T therapy in the treatment of various hematological malignancies, also, with a mention of its effect on solid tumors, for which they have not received FDA approval yet. Different common and uncommon side effects are also discussed in this paper, with attention to the effect of each drug separately. By reviewing the recommendations of the FDA for CAR-T therapy research, we have extensively discussed dose-limiting toxicities. This further highlights the need for precise dosing strategies, striking a balance between therapeutic benefits and potential risks. Additionally, we reviewed the long-term follow-up of patients receiving CAR-T therapy to gain valuable insights into response durability and late-onset effects. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Tumor-infiltrating B cells: Their dual mechanistic roles in the tumor microenvironment.
- Author
-
Xue, Demin, Hu, Shaozhen, Zheng, Runchen, Luo, Huidan, and Ren, Xi
- Subjects
- *
REGULATORY B cells , *B cells , *ANTIGEN presentation , *ANTIBODY formation , *T cells - Abstract
The occurrence and development of tumors are closely associated with abnormalities in the immune system's structure and function, with tumor immunotherapy being intricately linked to the tumor microenvironment (TME). Early studies on lymphocytes within the TME primarily concentrated on T cells. However, as research has advanced, the multifaceted roles of tumor-infiltrating B cells (TIL-Bs) in tumor immunity, encompassing both anti-tumor and pro-tumor effects, have garnered increasing attention. This paper explored the composition of the TME and the biological characteristics of TIL-Bs, investigating the dual roles within the TME to offer new insights and strategies for tumor immunotherapy. [Display omitted] • Dual roles of tumor-infiltrating B cells in tumor microenvironment: anti-tumor and pro-tumor effects. • Tumor-infiltrating B cells boost anti-tumor immunity via antigen presentation, antibody production, cytokine secretion, etc. • Regulatory B cells aid tumor immune evasion by releasing suppressive cytokines, specific antibodies, and metabolites. • Insights into Tumor-infiltrating B cells may offer potential new targets for cancer immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Primary Sjögren syndrome specific B cells induced aberrant surface aggregation of B cell receptors (BCRs) and signalling.
- Author
-
Haneef, Kabeer, Ahmed Khand, Aftab, Saleem Iqbal khan, Muhammad, Bano Channer, Husan, and Umer Asghar, Muhammad
- Subjects
B cell receptors ,IMMUNOGLOBULIN light chains ,B cells ,SJOGREN'S syndrome ,B cell lymphoma ,XEROSTOMIA - Abstract
• Continuous stimulation of autoreactive B cells by immune complexes is the first step towards the development of pSS. • Efficient regulation of hyperactivated B cells is crucial through the use of B cell receptor (BCR) targeting therapies to control clonal escape and the development of pSS. • pSS-specific B cells enhance the aggregation of BCRs at the B cell-APCs contact interface and trigger downstream signalling cascade events. Primary Sjögren's syndrome (pSS) is a systematic autoimmune manifestation of the exocrine glands caused by impaired lymphocytic infiltration, leading to dry eyes and xerostomia. The pathologic hallmark of this disease is the dysfunction of the exocrine glands, which results in dry eyes and mouth. Clinical observations suggest that B cells contribute to the pathogenesis of pSS through the enhanced secretion of autoantibodies, hypergammaglobulinemia, reduced free light chains, and a higher B cell lymphoma. Despite increased evidence of B cell hyperactivation and dysregulated B cell interactions in pSS, detailed speculations into the mechanism by which pSS-specific B cells exhibited abnormal BCR signaling repertoires and the magnitude of downstream signaling responses remain limited. Upon encountering antigens, B lymphocytes produce neutralizing antibodies by phosphorylating immune receptor tyrosine activation motifs (ITAMs). Despite these advancements, we still do not understand how pSS-specific B cells influence the surface clustering of BCRs and subsequent downstream immune responses. This paper hypothesizes that pSS-specific B cells encountering surrogate antigens will undergo a coordinated series of events that initiate B cell activation and spatiotemporal dynamics of BCRs. Additionally, we assume that pSS individuals have aberrant BCR repertoire and clonal expansion. In the future, these studies can provide detailed therapeutic entanglements for B cell-linked autoimmune and other hypersensitive disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Immunotherapeutic potential of collagen V oral administration in mBSA/CFA-induced arthritis.
- Author
-
Ramos da Silveira, Lizandre Keren, Velosa, Ana Paula P., Catanozi, Sergio, Pereira, Marco Aurélio A., dos Santos Filho, Antonio, Marques, Fabio Luiz N., de Paula Faria, Daniele, Real, Caroline Cristiano, Fernezlian, Sandra de M., Yanke, Amanda Flores, Queiroz, Zelita Aparecida de J., Contini, Vitória Elias, de Matos Lobo, Thays, Carrasco, Solange, Baldavira, Camila Machado, Goldenstein-Schainberg, Cláudia, Fuller, Ricardo, Capelozzi, Vera L., and Teodoro, Walcy R.
- Subjects
ORAL drug administration ,EXPERIMENTAL arthritis ,LABORATORY rats ,B cells ,SALINE injections - Abstract
We hypothesized that after synovial injury, collagen V (Col V) expose occult antigens, and Col V autoantibodies develop, indicating the loss of immune tolerance against this molecule, thus leading to damage to mesenchymal-derived cells as well as the extracellular matrix in experimental arthritis. Thus, the present study investigated the effects of oral administration of Col V on the synovium after the development of inflammation in mBSA/CFA-induced arthritis. After fourteen days of intraarticular administration of mBSA, 10 male Lewis rats were orally administered Col V (500 μg/300 μL) diluted in 0.01 N acetic acid (IA-Col V group). The arthritic group (IA group, n = 10) received only intraarticular mBSA. An intra-articular saline injection (20 μL) was given to the control group (CT-Col V, n = 5). IA group presented damaged synovia, the expansion of the extracellular matrix by cellular infiltrate, which was characterized by T and B lymphocytes, and fibroblastic infiltration. In contrast, after Col V oral immunotherapy IA-Col V group showed a significant reduction in synovial inflammation and intense expression of IL-10+ and FoxP3+ cells, in addition to a reduction in Col V and an increase in Col I in the synovia compared to those in the IA group. Furthermore, an increase in IL-10 production was detected after IA-Col V group spleen cell stimulation with Col V in vitro. PET imaging did not differ between the groups. The evaluation of oral treatment with Col V, after mBSA/CFA-induced arthritis in rats, protects against inflammation and reduces synovial tissue damage, through modulation of the synovial matrix, showing an immunotherapeutic potential in inhibiting synovitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. New generalized metric based on branch length distance to compare B cell lineage trees.
- Author
-
Farnia, Mahsa and Tahiri, Nadia
- Subjects
B cell differentiation ,HEMATOPOIETIC stem cells ,B cells ,TREE branches ,IMMUNE system - Abstract
The B cell lineage tree encapsulates the successive phases of B cell differentiation and maturation, transitioning from hematopoietic stem cells to mature, antibody-secreting cells within the immune system. Mathematically, this lineage can be conceptualized as an evolutionary tree, where each node represents a distinct stage in B cell development, and the edges reflect the differentiation pathways. To compare these lineage trees, a rigorous mathematical metric is essential. Analyzing B cell lineage trees mathematically and quantifying changes in lineage attributes over time necessitates a comparison methodology capable of accurately assessing and measuring these changes. Addressing the intricacies of multiple B cell lineage tree comparisons, this study introduces a novel metric that enhances the precision of comparative analysis. This metric is formulated on principles of metric theory and evolutionary biology, quantifying the dissimilarities between lineage trees by measuring branch length distance and weight. By providing a framework for systematically classifying lineage trees, this metric facilitates the development of predictive models that are crucial for the creation of targeted immunotherapy and vaccines. To validate the effectiveness of this new metric, synthetic datasets that mimic the complexity and variability of real B cell lineage structures are employed. We demonstrated the ability of the new metric method to accurately capture the evolutionary nuances of B cell lineages. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.
- Author
-
Brinkkemper, Mitch, Kerster, Gius, Brouwer, Philip J. M., Tran, Andy S., Torres, Jonathan L., Ettema, Roos A., Nijhuis, Haye, Allen, Joel D., Zhu, Wenwen, Gao, Hongmei, Lee, Wen-Hsin, Bijl, Tom P. L., Snitselaar, Jonne L., Burger, Judith A., Bontjer, Ilja, Olijhoek, Wouter, Ravichandran, Rashmi, van Breemen, Marielle J., Del Moral-Sánchez, Iván, and Derking, Ronald
- Subjects
ANTIBODY formation ,HIV ,VACCINE effectiveness ,NANOPARTICLES ,EPITOPES ,MONOCLONAL antibodies ,B cells - Abstract
An effective human immunodeficiency virus 1 (HIV-1) vaccine will most likely have to elicit broadly neutralizing antibodies (bNAbs) to overcome the sequence diversity of the envelope glycoprotein (Env). So far, stabilized versions of Env, such as SOSIP trimers, have been able to induce neutralizing antibody (NAb) responses, but those responses are mainly strain-specific. Here we attempted to broaden NAb responses by using a multivalent vaccine and applying a number of design improvements. First, we used highly stabilized SOSIP.v9 trimers. Second, we removed any holes in the glycan shields and optimized glycan occupancy to avoid strain-specific glycan hole responses. Third, we selected five sequences from the same clade (B), as we observed previously that combining Env trimers from clade A, B and C did not improve cross-reactive responses, as they might have been too diverse. Fourth, to improve antibody (Ab) responses, the Env trimers were displayed on two-component I53-50 nanoparticles (NPs). Fifth, to favor activation of cross-reactive B cells, the five Env trimers were co-displayed on mosaic NPs. Sixth, we immunized rabbits four times with long intervals between vaccinations. These efforts led to the induction of cross-reactive B cells and cross-reactive binding Ab responses, but we only sporadically detected cross-neutralizing responses. We conclude that stabilized HIV-1 Env trimers that are not modified specifically for priming naive B cells are unable to elicit strong bNAb responses, and infer that sequential immunization regimens, most likely starting with specific germline-targeting immunogens, will be necessary to overcome Env's defenses against the induction of NAbs. The antigens described here could be excellent boosting immunogens in a sequential immunization regimen, as responses to bNAb epitopes were induced. Author summary: The overall consensus in the HIV-1 vaccine field is that an effective vaccine should be able to elicit broadly neutralizing responses. In this study we aimed at inducing a cross-neutralizing antibody response using stabilized HIV-1 envelope trimers. We applied a multitude of state-of-the-art antigen design approaches to achieve this goal. Despite these efforts, our immunogens did not induce cross-neutralizing responses efficiently. In-depth analysis of the antibody responses, and antigen-specific B cells elicited by the vaccinations revealed interesting details that can help guide future vaccine design. Presenting the mature envelope proteins on a mixture of monovalent nanoparticles, or co-displayed on a mosaic nanoparticle, induced different amounts of cross-reactive cells. Furthermore, we found that the immunogens used in this study were in some cases able to induce antibody responses to broadly neutralizing epitopes, indicating that these immunogens could be useful in alternative vaccination strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network.
- Author
-
Klinger, Bertram, Rausch, Isabel, Sieber, Anja, Kutz, Helmut, Kruse, Vanessa, Kirchner, Marieluise, Mertins, Philipp, Kieser, Arnd, Blüthgen, Nils, and Kube, Dieter
- Subjects
DIFFUSE large B-cell lymphomas ,B cell lymphoma ,MITOGEN-activated protein kinases ,B cells ,CELL receptors - Abstract
B cell receptor (BCR) signaling is required for the survival and maturation of B cells and is deregulated in B cell lymphomas. While proximal BCR signaling is well studied, little is known about the crosstalk of downstream effector pathways, and a comprehensive quantitative network analysis of BCR signaling is missing. Here, we semi-quantitatively modelled BCR signaling in Burkitt lymphoma (BL) cells using systematically perturbed phosphorylation data of BL-2 and BL-41 cells. The models unveiled feedback and crosstalk structures in the BCR signaling network, including a negative crosstalk from p38 to MEK/ERK. The relevance of the crosstalk was verified for BCR and CD40 signaling in different BL cells and confirmed by global phosphoproteomics on ERK itself and known ERK target sites. Compared to the starting network, the trained network for BL-2 cells was better transferable to BL-41 cells. Moreover, the BL-2 network was also suited to model BCR signaling in Diffuse large B cell lymphoma cells lines with aberrant BCR signaling (HBL-1, OCI-LY3), indicating that BCR aberration does not cause a major downstream rewiring. Author summary: B cell receptors bind specific antigens, and upon binding, they activate a signal transduction network which ultimately primes the cells for proliferation and affinity maturation. B-cell receptor signaling is often altered in B-cell lymphoma, leading to altered or chronic activation of the network. In this study we compared the signal transduction network downstream of acute and aberrant B cell receptor activity in cell lines originating from Burkitt and diffuse large B-cell lymphoma, respectively. By applying kinase inhibitors, we measured phosphorylation state changes in the network nodes. Mathematical modeling revealed a 16-node core network conserved in cells with acute and abberant B cell receptor signaling. In the network we detected hitherto undescribed crosstalks and feedbacks, structures known to confer treatment robustness. We elucidated and verified a negative crosstalk between the mitogen-activated protein kinases (MAPK) p38 and ERK. We further discovered that the negative feedback from ERK to its upstream kinase RAF, which in solid tumors neutralizes treatments targeting ERK or MEK, is also present in B cells. Altogether these findings may inform future treatment strategies targeting overactive B cell receptor or help to explain treatment resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Age-associated changes in innate and adaptive immunity: role of the gut microbiota.
- Author
-
Haoyu Gao, Nepovimova, Eugenie, Adam, Vojtech, Heger, Zbynek, Valko, Marian, Qinghua Wu, and Kuca, Kamil
- Subjects
OLDER people ,GUT microbiome ,NATURAL immunity ,HUMAN microbiota ,B cells - Abstract
Aging is generally regarded as an irreversible process, and its intricate relationship with the immune system has garnered significant attention due to its profound implications for the health and well-being of the aging population. As people age, a multitude of alterations occur within the immune system, affecting both innate and adaptive immunity. In the realm of innate immunity, aging brings about changes in the number and function of various immune cells, including neutrophils, monocytes, and macrophages. Additionally, certain immune pathways, like the cGAS-STING, become activated. These alterations can potentially result in telomere damage, the disruption of cytokine signaling, and impaired recognition of pathogens. The adaptive immune system, too, undergoes a myriad of changes as age advances. These include shifts in the number, frequency, subtype, and function of T cells and B cells. Furthermore, the human gut microbiota undergoes dynamic changes as a part of the aging process. Notably, the interplay between immune changes and gut microbiota highlights the gut's role in modulating immune responses and maintaining immune homeostasis. The gut microbiota of centenarians exhibits characteristics akin to those found in young individuals, setting it apart from the microbiota observed in typical elderly individuals. This review delves into the current understanding of how aging impacts the immune system and suggests potential strategies for reversing aging through interventions in immune factors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Examining the influence of tumor-infiltrating macrophages on breast cancer outcomes and identifying relevant genes for diagnostic purposes.
- Author
-
Zhang, Xiaoyun, Peng, Cheng, Xiong, Xuesong, and Lian, Jianchun
- Subjects
BREAST cancer prognosis ,CANCER prognosis ,BREAST cancer ,B cells ,CANCER cells - Abstract
Objective: The purpose of this research was to investigate how different types of immune cells impact the outlook of individuals with breast cancer, as well as identify the essential genes associated with immune cell subtype enrichment. Methods: The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) database were used to obtain global transcriptome sequencing data sets of breast tissue. The study utilized the CIBERSORT algorithm to determine the presence of 22 different types of immune cells in both breast cancer tissue and normal breast tissue.Immune cell infiltration content was utilized to conduct univariate COX analysis in order to identify risk factors linked to breast cancer prognosis. Results: Univariate COX analysis indicates that Macrophages M1 and B cells naive are beneficial factors for the outlook of individuals with breast cancer (P < 0.05), while Macrophages M2 and Monocytes are detrimental factors for the prognosis of breast cancer patients (P < 0.05). The high infiltration group of macrophage M2 had a poorer prognosis compared to the low infiltration group (P < 0.001); Conversely, the high infiltration group of macrophage M1 had a better prognosis than the low infiltration group (P = 0.002). Conclusion: The study provided an overview of immune cell infiltration in breast cancer tissues, identifying macrophage M1 and macrophage M2 as potential factors in breast cancer development and progression. Additionally, genes associated with macrophage phenotype were analyzed, offering insights into macrophage polarization mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.
- Author
-
Rowntree, Louise C., Audsley, Jennifer, Allen, Lilith F., McQuilten, Hayley A., Hagen, Ruth R., Chaurasia, Priyanka, Petersen, Jan, Littler, Dene R., Hyon-Xhi Tan, Murdiyarso, Lydia, Habel, Jennifer R., Foo, Isabelle J. H., Wuji Zhang, Ten Berge, Elizabeth R. V., Ganesh, Hanujah, Kaewpreedee, Prathanporn, Lee, Kelly W. K., Cheng, Samuel M. S., Kwok, Janette S. Y., and Jayasinghe, Dhilshan
- Subjects
COVID-19 ,POST-acute COVID-19 syndrome ,T cell receptors ,T cells ,B cells - Abstract
Long COVID occurs in a small but important minority of patients following COVID-19, reducing quality of life and contributing to healthcare burden. Although research into underlying mechanisms is evolving, immunity is understudied. SARS-CoV-2-specific T cell responses are of key importance for viral clearance and COVID-19 recovery. However, in long COVID, the establishment and persistence of SARS-CoV-2-specific T cells are far from clear, especially beyond 12 mo postinfection and postvaccination. We defined ex vivo antigen-specific B cell and T cell responses and their T cell receptors (TCR) repertoires across 2 y postinfection in people with long COVID. Using 13 SARS-CoV-2 peptide-HLA tetramers, spanning 11 HLA allotypes, as well as spike and nucleocapsid probes, we tracked SARS-CoV-2-specific CD8+ and CD4
+ T cells and B-cells in individuals from their first SARS-CoV-2 infection through primary vaccination over 24 mo. The frequencies of ORF1a-and nucleocapsid-specific T cells and B cells remained stable over 24 mo. Spike-specific CD8+ and CD4+ T cells and B cells were boosted by SARS-CoV-2 vaccination, indicating immunization, in fully recovered and people with long COVID, altered the immunodominance hierarchy of SARS-CoV-2 T cell epitopes. Meanwhile, influenza-specific CD8+ T cells were stable across 24 mo, suggesting no bystander-activation. Compared to total T cell populations, SARS-CoV-2-specific T cells were enriched for central memory phenotype, although the proportion of central memory T cells decreased following acute illness. Importantly, TCR repertoire composition was maintained throughout long COVID, including postvaccination, to 2 y postinfection. Overall, we defined ex vivo SARS-CoV-2-specific B cells and T cells to understand primary and recall responses, providing key insights into antigen-specific responses in people with long COVID. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
35. B cells drive neuropathic pain–related behaviors in mice through IgG–Fc gamma receptor signaling.
- Author
-
Lacagnina, Michael J., Willcox, Kendal F., Boukelmoune, Nabila, Bavencoffe, Alexis, Sankaranarayanan, Ishwarya, Barratt, Daniel T., Zuberi, Younus A., Dayani, Dorsa, Chavez, Melissa V., Lu, Jonathan T., Farinotti, Alex Bersellini, Shiers, Stephanie, Barry, Allison M., Mwirigi, Juliet M., Tavares-Ferreira, Diana, Funk, Geoffrey A., Cervantes, Anna M., Svensson, Camilla I., Walters, Edgar T., and Hutchinson, Mark R.
- Subjects
DORSAL root ganglia ,PERIPHERAL nerve injuries ,IMMUNE complexes ,CELL populations ,B cells - Abstract
Neuroimmune interactions are essential for the development of neuropathic pain, yet the contributions of distinct immune cell populations have not been fully unraveled. Here, we demonstrate the critical role of B cells in promoting mechanical hypersensitivity (allodynia) after peripheral nerve injury in male and female mice. Depletion of B cells with a single injection of anti-CD20 monoclonal antibody at the time of injury prevented the development of allodynia. B cell–deficient (muMT) mice were similarly spared from allodynia. Nerve injury was associated with increased immunoglobulin G (IgG) accumulation in ipsilateral lumbar dorsal root ganglia (DRGs) and dorsal spinal cords. IgG was colocalized with sensory neurons and macrophages in DRGs and microglia in spinal cords. IgG also accumulated in DRG samples from human donors with chronic pain, colocalizing with a marker for macrophages and satellite glia. RNA sequencing revealed a B cell population in naive mouse and human DRGs. A B cell transcriptional signature was enriched in DRGs from human donors with neuropathic pain. Passive transfer of IgG from injured mice induced allodynia in injured muMT recipient mice. The pronociceptive effects of IgG are likely mediated through immune complexes interacting with Fc gamma receptors (FcγRs) expressed by sensory neurons, microglia, and macrophages, given that both mechanical allodynia and hyperexcitability of dissociated DRG neurons were abolished in nerve-injured FcγR-deficient mice. Consistently, the pronociceptive effects of IgG passive transfer were lost in FcγR-deficient mice. These data reveal that a B cell–IgG–FcγR axis is required for the development of neuropathic pain in mice. Editor's summary: B cells contribute to the pathogenesis of neuropathic pain, but the exact mechanisms remain elusive. Lacagnina et al. report increased immunoglobulin G (IgG) in the dorsal root ganglia (DRGs) of mice after peripheral nerve injury (PNI) and patients with chronic pain. Passive transfer of IgG from injured wild-type mice elicited allodynia in PNI mice without B cells (muMT) that were otherwise protected from allodynia. Mice lacking the Fc gamma receptor (FcγR) were also protected from allodynia, and this receptor was necessary for the development of hyperexcitability in DRG neurons upon PNI. The identified B cell–IgG–FcγR axis could help to develop alternative treatment avenues for neuropathic pain. —Daniela Neuhofer [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms.
- Author
-
Xinyue Zhao, Donghe Han, Chun Zhao, Fengfan Yang, Zhimei Wang, Yujiao Gao, Meihua Jin, and Ran Tao
- Subjects
MITOGEN-activated protein kinases ,TRANSFORMING growth factors ,TOLL-like receptors ,INFLAMMATION ,B cells - Abstract
As the body's defense mechanism against damage and infection, the inflammatory response is a pathological process that involves a range of inflammatory cells and cytokines. A healthy inflammatory response helps the body repair by eliminating dangerous irritants. However, tissue fibrosis can result from an overly intense or protracted inflammatory response. The anti-aging gene Klotho suppresses oxidation, delays aging, and fosters development of various organs. Numerous investigations conducted in the last few years have discovered that Klotho expression is changed in a variety of clinical diseases and is strongly linked to the course and outcome of a disease. Klotho functions as a co-receptor for FGF and as a humoral factor that mediates intracellular signaling pathways such as transforming growth factor β (TGF-β), toll-like receptors (TLRs), nuclear factor-kappaB (NF-κB), renin -angiotensin system (RAS), and mitogen-activated protein kinase (MAPK). It also interferes with the phenotype and function of inflammatory cells, such as monocytes, macrophages, T cells, and B cells. Additionally, it regulates the production of inflammatory factors. This article aims to examine Klotho's scientific advances in terms of tissue fibrosis and the inflammatory response in order to provide novel therapy concepts for fibrotic and inflammatory disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. An update on leprosy immunopathogenesis: systematic review.
- Author
-
Abrahão Silva, Marcos Jessé, Soares Silva, Caroliny, Pinto Brasil, Thiago, Karoliny Alves, Ana, Cordeiro dos Santos, Everaldina, Cunha Frota, Cristiane, Batista Lima, Karla Valéria, and Gondim Costa Lima, Luana Nepomuceno
- Subjects
SCIENTIFIC knowledge ,MYCOBACTERIUM leprae ,PATHOLOGY ,T cells ,B cells - Abstract
Introduction: Leprosy is a chronic infectious condition and the main cause of neuropathy that occurs brought on by M. leprae. It is known that the biological characteristics of the human host, such as the immunological ones, have a higher influence on the pathology of this disease than the intrinsic mechanisms of the bacterium. The objective of this work was to review the scientific knowledge about the relationship between immunopathology and the severity of leprosy. Methods: A systematic review following the PRISMA 2020 recommendations was conducted in the PUBMED, LILACS, SciELO and Science Direct databases using articles in English, Portuguese or Spanish between January 2011 and May 2022 with the descriptors "Leprosy/Immunology", "Cytokines" and "Mycobacterium leprae". A methodological quality assessment was carried out using the JBI checklists. Results: A total of 49 articles were included. There is a relationship of greater severity of infection associated with lower release of MHC molecules in response to PGL-1 that inhibit the promotion of resolving T lymphocytes arising from dendritic cells (DCs) stimulation. In addition, the differentiation of macrophage phenotypes dependent on the activation of PRRs can define activation and the distinct type of T helper (Th) cells involved according to severity. Activated CD8+ T cells also have distinct types at the appropriate poles of the disease, and B cells show at the most severe pole of the LL, specific induction of IgA and more Treg-type CD8+ T cells that further contribute to T cell anergy. Conclusion: Therefore, the adaptive immune system aggravates nerve damage and defines the type of leprosy, while the innate immune system is considerably more significant in the onset of nerve damage, symptomatic of the initial presentation of illness and in several critical immune responses, including inflammation and elimination of dead M. leprae. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation.
- Author
-
van der Lans, Sjors P. A., Bardoel, Bart W., Ruyken, Maartje, de Haas, Carla J. C., Baijens, Stan, Muts, Remy M., Scheepmaker, Lisette M., Aerts, Piet C., van 't Wout, Marije F. L., Preiner, Johannes, Marijnissen, Renoud J., Schuurman, Janine, Beurskens, Frank J., Kerkman, Priscilla F., and Rooijakkers, Suzan H. M.
- Subjects
IMMUNOLOGIC memory ,BACTERIAL cells ,NOSOCOMIAL infections ,CELL surface antigens ,COMPLEMENT activation ,B cells - Abstract
Antibody-dependent complement activation plays a key role in the natural human immune response to infections. Currently, the understanding of which antibody-antigen combinations drive a potent complement response on bacteria is limited. Here, we develop an antigen-agnostic approach to stain and single-cell sort human IgG memory B cells recognizing intact bacterial cells, keeping surface antigens in their natural context. With this method we successfully identified 29 antibodies against K. pneumoniae, a dominant cause of hospital-acquired infections with increasing antibiotic resistance. Combining genetic tools and functional analyses, we reveal that the capacity of antibodies to activate complement on K. pneumoniae critically depends on their antigenic target. Furthermore, we find that antibody combinations can synergistically activate complement on K. pneumoniae by strengthening each other's binding in an Fc-independent manner. Understanding the molecular basis of effective complement activation by antibody combinations to mimic a polyclonal response could accelerate the development of antibody-based therapies against problematic infections. Here, van der Lans et al describe an antigen-agnostic approach to identify antibodies against Klebsiella pneumoniae. Functional analysis of these antibodies indicates that their capacity to activate complement depends on their antigenic target. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Pre-analytical stability of ocrelizumab in serum after delayed centrifugation of whole blood.
- Author
-
Shim, Jeongsup, Carrasco-Triguero, Montserrat, and Fischer, Saloumeh K.
- Subjects
PATIENT compliance ,MEDICAL personnel ,HEALTH facilities ,OLDER patients ,SUBCUTANEOUS injections ,DOSE-response relationship (Radiation) ,B cells - Abstract
This article examines the stability of ocrelizumab, a medication used to treat multiple sclerosis, when blood samples are delayed in centrifugation. The study finds that delaying centrifugation for up to 24 hours at room temperature does not significantly impact the concentration of ocrelizumab in the serum. This research is important for evaluating the feasibility of in-home blood collection for patients with mobility disabilities, as it can improve convenience and adherence to treatment. While the findings suggest that in-home collection may be applicable to other similar medications, further studies are needed for confirmation. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
40. An intranasal cationic liposomal polysaccharide vaccine elicits humoral immune responses against Streptococcus pneumoniae.
- Author
-
Wei, Peng, Romanò, Cecilia, Li, Chengxin, Clergeaud, Gael, Andresen, Thomas L., Henriksen, Jonas R., Hansen, Anders E., and Clausen, Mads H.
- Subjects
CATIONIC lipids ,STREPTOCOCCUS pneumoniae ,PNEUMOCOCCAL vaccines ,CHILD mortality ,POLYSACCHARIDES ,B cells - Abstract
Diseases caused by S. pneumoniae are the leading cause of child mortality. As antibiotic resistance of S. pneumoniae is rising, vaccination remains the most recommended solution. However, the existing pneumococcal polysaccharides vaccine (Pneumovax
® 23) proved only to induce T-independent immunity, and strict cold chain dependence of the protein conjugate vaccine impedes its promotion in developing countries, where infections are most problematic. Affordable and efficient vaccines against pneumococcus are therefore in high demand. Here, we present an intranasal vaccine Lipo+ CPS12F&αGC, containing the capsular polysaccharides of S. pneumoniae 12F and the iNKT agonist α-galactosylceramide in cationic liposomes. In BALB/cJRj mice, the vaccine effectively activates iNKT cells and promotes B cells maturation, stimulates affinity-matured IgA and IgG production in both the respiratory tract and systemic blood, and displays sufficient protection both in vivo and in vitro. The designed vaccine is a promising, cost-effective solution against pneumococcus, which can be expanded to cover more serotypes and pathogens. Intranasal immunization with capsular pneumococcal polysaccharides 12F and iNKT agonist α-galactosylceramide in cationic liposomes protects mice from S. pneumoniae 12F infection. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
41. Maf expression in B cells restricts reactive plasmablast and germinal center B cell expansion.
- Author
-
Hillion, Sophie, Miranda, Anjelica, Le Dantec, Christelle, Boudigou, Marina, Le Pottier, Laëtitia, Cornec, Divi, Torres, Raul M., and Pelanda, Roberta
- Subjects
B cell differentiation ,PLASMA cells ,B cells ,TRANSCRIPTION factors ,IMMUNOLOGIC memory - Abstract
Precise regulation of B cell differentiation is essential for an effective adaptive immune response. Here, we show that B cell development in mice with B cell-specific Maf deletion is unaffected, but marginal zone B cells, germinal centre B cells, and plasmablasts are significantly more frequent in the spleen of naive Maf-deficient mice compared to wild type controls. In the context of a T cell-dependent immunization, Maf deletion causes increased proliferation of germinal centre B cells and extrafollicular plasmablasts. This is accompanied by higher production of antigen-specific IgG1 antibodies with minimal modification of early memory B cells, but a reduction in plasma cell numbers. Single-cell RNA sequencing shows upregulation of genes associated with DNA replication and cell cycle progression, confirming the role of Maf in cell proliferation. Subsequent pathway analysis reveals that Maf influences cellular metabolism, transporter activity, and mitochondrial proteins, which have been implicated in controlling the germinal centre reaction. In summary, our findings demonstrate that Maf acts intrinsically in B cells as a negative regulator of late B cell differentiation, plasmablast proliferation and germinal centre B cell formation. Maf is a transcription factor regulating pivotal biological processes in multiple immune cells, but its B-cell-intrinsic role is not fully known. Here authors show that genomic deletion of Maf in the B cell lineage does not disturb the sequence of developmental stages, however, removes an important inhibitory step to restrict the early steps of germinal centre B cell and extrafollicular plasmablast population expansion. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Lymphocyte subsets for predicting inflammatory bowel disease progression and treatment response: a systematic review.
- Author
-
Rirong Chen, Chao Li, Jieqi Zheng, Zinan Fan, Li Li, Minhu Chen, Baili Chen, and Shenghong Zhang
- Subjects
INFLAMMATORY bowel diseases ,LYMPHOCYTE subsets ,T cells ,TUMOR necrosis factors ,B cells - Abstract
Background: Lymphocytes play a key role in the pathogenesis of inflammatory bowel disease (IBD) and are widely explored as promising prognostic indicators. We aimed to outline the existing evidences on the capability of lymphocyte subpopulations to predict disease progression and treatment response in patients with IBD. Methods: The protocol for this review was registered in PROSPERO (registration ID: CRD 42022364126). Systematic retrieval was conducted using PubMed, Embase, and Web of Science databases. Original articles on the prognostic value of lymphocyte subsets in IBD published up to April 8, 2023 were eligible for inclusion. The Newcastle–Ottawa Scale was used to evaluate the risk of bias. Results: Twenty studies were ultimately included: eight evaluated the prediction of disease progression and 12 focused on the prediction of treatment response. According to the Newcastle–Ottawa Scale, three studies were of high quality, 16 were of moderate quality, and only one was of low quality. T-cell subpopulations, including CD4
+ T cells, CD8+ T cells, and gd T cells, are revealed to have prognostic capacity. Transmembrane tumor necrosis factor a-bearing lymphocytes, CD4+ T cells, CD8+ T cells, and Plasma cells are found to have the potential to predict the response to anti-TNFα agents. In contrast memory T cells, CD4+ T cells, and naïve B cells may predict the response to vedolizumab. Conclusions: This systematic review identified several potential lymphocyte subset-related predictors. If verified in large cohort prospective studies, these findings could aid clinical decision-making. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
43. Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.
- Author
-
Jin, Ying, Wu, Yuefeng, Reuben, Alexandre, Zhu, Liang, Gay, Carl M., Wu, Qingzhe, Zhou, Xintong, Mo, Haomin, Zheng, Qi, Ren, Junyu, Fang, Zhaoyuan, Peng, Teng, Wang, Nan, Ma, Liang, Fan, Yun, Song, Hai, Zhang, Jianjun, and Chen, Ming
- Subjects
SMALL cell lung cancer ,B cells ,RNA metabolism ,HETEROGENEITY ,NEST predation - Abstract
Small cell lung cancer (SCLC) is an aggressive pulmonary neuroendocrine malignancy featured by cold tumor immune microenvironment (TIME), limited benefit from immunotherapy, and poor survival. The spatial heterogeneity of TIME significantly associated with anti-tumor immunity has not been systemically studied in SCLC. We performed ultra-high-plex Digital Spatial Profiling on 132 tissue microarray cores from 44 treatment-naive limited-stage SCLC tumors. Incorporating single-cell RNA-sequencing data from a local cohort and published SCLC data, we established a spatial proteo-transcriptomic landscape covering over 18,000 genes and 60 key immuno-oncology proteins that participate in signaling pathways affecting tumorigenesis, immune regulation, and cancer metabolism across 3 pathologically defined spatial compartments (pan-CK-positive tumor nest; CD45/CD3-positive tumor stroma; para-tumor). Our study depicted the spatial transcriptomic and proteomic TIME architecture of SCLC, indicating clear intra-tumor heterogeneity dictated via canonical neuroendocrine subtyping markers; revealed the enrichment of innate immune cells and functionally impaired B cells in tumor nest and suggested potentially important immunoregulatory roles of monocytes/macrophages. We identified RE1 silencing factor (REST) as a potential biomarker for SCLC associated with low neuroendocrine features, more active anti-tumor immunity, and prolonged survival. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Two-dose priming immunization amplifies humoral immunity by synchronizing vaccine delivery with the germinal center response.
- Author
-
Bhagchandani, Sachin H., Yang, Leerang, Lam, Jonathan H., Maiorino, Laura, Ben-Akiva, Elana, Rodrigues, Kristen A., Romanov, Anna, Suh, Heikyung, Aung, Aereas, Wu, Shengwei, Wadhera, Anika, Chakraborty, Arup K., and Irvine, Darrell J.
- Subjects
FOLLICULAR dendritic cells ,PEPTIDE vaccines ,T helper cells ,HUMORAL immunity ,B cells - Abstract
Prolonging exposure to subunit vaccines during the primary immune response enhances humoral immunity. Escalating-dose immunization (EDI), administering vaccines every other day in an increasing pattern over 2 weeks, is particularly effective but challenging to implement clinically. Here, using an HIV Env trimer/saponin adjuvant vaccine, we explored simplified EDI regimens and found that a two-shot regimen administering 20% of the vaccine followed by the remaining 80% of the dose 7 days later increased T
FH responses 6-fold, antigen-specific germinal center (GC) B cells 10-fold, and serum antibody titers 10-fold compared with bolus immunization. Computational modeling of TFH priming and the GC response suggested that enhanced activation/antigen loading on dendritic cells and increased capture of antigen delivered in the second dose by follicular dendritic cells contribute to these effects, predictions we verified experimentally. These results suggest that a two-shot priming approach can be used to substantially enhance responses to subunit vaccines. Editor's summary: A key feature of effective vaccines is that the delivery strategy optimizes immune responses. Bhagchandani et al. sought to optimize immune responses using prolonged exposure to a protein subunit vaccine called escalating-dose immunization (EDI). They immunized mice with an adjuvanted HIV envelope protein subunit and tested different numbers of doses, dose ratios, and time intervals between doses. A two-dose regimen for which 20% of the vaccine was administered in the first dose and 80% was given in the second dose 7 days later induced effective follicular helper T cell and antigen-specific germinal center B cell responses that were also reflected in higher antibody titers. This response was linked to enhanced antigen capture and presentation by dendritic cells. —Christiana Fogg [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
45. Ex Vivo Analysis of the Association of GFP-Expressing L. aethiopica and L. mexicana with Human Peripheral Blood-Derived (PBD) Leukocytes over 24 Hours.
- Author
-
Ranatunga, Medhavi, Deacon, Andrew, Harbige, Laurence S., Dyer, Paul, Boateng, Joshua, and Getti, Giulia T. M.
- Subjects
REGULATORY T cells ,B cells ,FIBROBLASTS ,LEUCOCYTES ,DENDRITIC cells ,T cells - Abstract
Leishmania parasites are transmitted to mammalian hosts through the bite of sandflies. These parasites can infect phagocytic cells (macrophages, dendritic cells, and neutrophils) and non-phagocytic cells (B cells and fibroblasts). In mice models, the disease development or resolution is linked to T cell responses involving inflammatory cytokines and the activation of macrophages with the M1/M2 phenotype. However, this mechanism does not apply to human infection where a more complex immunological response occurs. The understanding of interactions between immune cells during Leishmania infection in humans is still limited, as current infection models focus on individual cell types or late infection using controlled human infection models (CHIMs). This study investigated the early parasite infection in freshly isolated peripheral blood-derived (PBD) leukocytes over 24 h. Flow cytometer analysis is used in immunophenotyping to identify different subpopulations. The study found that among the L. aethiopica
GFP -associated leukocytes, most cells were neutrophils (55.87% ± 0.09 at 4 h) and monocytes (23.50% ± 0.05% at 24 h). B cells were 12.43% ± 0.10% at 24 h. Additionally, 10–20% of GFP+ leukocytes did not belong to the aforementioned cell types, and further investigation revealed their identity as CD4+ T cells. Data not only confirm previous findings of Leishmania infection with PBD leukocytes and association with B cells but also suggest that CD4+ T cells might influence the early-stage of infection. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
46. Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome.
- Author
-
Santana-de Anda, Karina, Torres-Ruiz, Jiram, Mejía-Domínguez, Nancy R., Alcalá-Carmona, Beatriz, Maravillas-Montero, José L., Páez-Franco, José Carlos, Vargas-Castro, Ana Sofía, Lira-Luna, Jaquelin, Camacho-Morán, Emmanuel A., Juarez-Vega, Guillermo, Meza-Sánchez, David, Núñez-Álvarez, Carlos, Rull-Gabayet, Marina, and Gómez-Martín, Diana
- Subjects
POST-acute COVID-19 syndrome ,COVID-19 ,IMMUNOSPECIFICITY ,B cells ,GRANULOCYTES - Abstract
The coronavirus disease 2019 (COVID-19) survivors are frequently observed to present persistent symptoms constituting what has been called "post-acute COVID-19 syndrome" (PACS) or "long COVID-19". Some clinical risk factors have been identified to be associated with PACS development; however, specific mechanisms responsible for PACS pathology remain unknown. This study investigates clinical, immunological, and metabolomic risk factors associated with post-acute COVID-19 syndrome (PACS) in 51 patients, assessed 7–19 months after acute infection. Among the participants, 62.7% were male and 37.2% were female, with an average age of 47.8 years. At the follow-up, 37.2% met the criteria for PACS, revealing significant differences in immunological and metabolomic profiles at the time of acute infection. Patients with PACS were characterized by elevated levels of mature low-density granulocytes (LDGs), interleukin-8 (IL-8), pyruvate, pseudouridine, and cystine. Baseline multivariate analysis showed increased pyruvate and decreased alpha tocopherol levels. At follow-up, there was a decrease in absolute B lymphocytes and an increase in non-classical monocytes and 3-hydroxyisovaleric acid levels. These findings suggest that specific immunological and metabolomic markers during acute infection can help identify patients at higher risk of developing persistent PACS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. IgG4-Related Disease (IgG4-RD) with Unique Combined Generalized Skin Rashes and Biliary Tract Manifestation: A Comprehensive Immunological Analysis.
- Author
-
Jung, Ye La, Agrawal, Sudhanshu, Wang, Beverly, and Gupta, Sudhir
- Subjects
REGULATORY B cells ,REGULATORY T cells ,T helper cells ,LYMPHOCYTE subsets ,B cells - Abstract
IgG4-RD is a multisystem fibroinflammatory disease characterized by the infiltration of tissues by IgG4 plasma cells. Combined skin and biliary tract involvement in IgG4-RD has not been described. We present perhaps the most comprehensive analysis of lymphocyte subsets in the first case of IgG4-related generalized skin rash and first case of combined skin and biliary tract manifestations. A 55-year-old male presented with painful jaundice and generalized macular pigmented pruritic eruptions, and CT abdomen revealed biliary obstruction. Ampulla and skin biopsies were subjected to histology and immunostaining. Naïve, central memory (T
CM ), effector memory (TEM ), terminally differentiated effector memory (TEMRA ) subsets of CD4+ and CD8+ T cells, T follicular helper subsets, naïve, transitional, marginal zone (MZ), germinal center (GC), IgM memory, and class-switched memory (CSM) B cells, and T follicular regulatory, regulatory B cells, CD4 Treg, and CD8 Treg were analyzed. Serum IgG4 was elevated at 448 mg/dL. Ampula biopsy showed lamina propria fibrosis and increased IgG4-positive plasma cells. Skin punch biopsy showed lymphoplasmacytic infiltrates with a 67% ratio of IgG4+:IgG+ plasma cells. CD4+TN and CD4+TCM decreased, whereas CD4+TEM increased. Naïve B cells increased; transitional, MZ, CSM, GC B cells, and plasmablasts decreased compared to control. CD4 Treg increased, whereas CD8 Treg and Breg decreased. In conclusion, IgG-RD may present with combined biliary tract and generalized dermatological manifestations. Changes in regulatory lymphocytes suggest their role in the pathogenesis of IgG4-RD. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
48. Diterpenoids with Potent Anti-Psoriasis Activity from Euphorbia helioscopia L.
- Author
-
Zhao, Zhen-Zhu, Liang, Xu-Bo, He, Hong-Juan, Xue, Gui-Min, Sun, Yan-Jun, Chen, Hui, Zhao, Yin-Sheng, Bian, Li-Na, Feng, Wei-Sheng, and Zheng, Xiao-Ke
- Subjects
B cells ,INHIBITION of cellular proliferation ,DITERPENES ,T cells ,EUPHORBIA - Abstract
Psoriasis, an immune-mediated inflammatory skin disorder, seriously affects the quality of life of nearly four percent of the world population. Euphorbia helioscopia L. is the monarch constituent of Chinese ZeQi powder preparation for psoriasis, so it is necessary to illustrate its active ingredients. Thus, twenty-three diterpenoids, including seven new ones, were isolated from the whole herb of E. helioscopia L. Compounds 1 and 2, each featuring a 2,3-dicarboxylic functionality, are the first examples in the ent-2,3-sceo-atisane or the ent-2,3-sceo-abietane family. Extensive spectroscopic analysis (1D, 2D NMR, and HRMS data) and computational methods were used to confirm their structures and absolute configurations. According to the previous study and NMR data from the jatropha diterpenes obtained in this study, some efficient
1 H NMR spectroscopic rules for assigning the relative configurations of 3α-benzyloxy-jatroph-11E-ene and 7,8-seco-3α-benzyloxy-jatropha-11E-ene were summarized. Moreover, the hyperproliferation of T cells and keratinocytes is considered a key pathophysiology of psoriasis. Anti-proliferative activities against induced T/B lymphocytes and HaCaT cells were tested, and IC50 values of some compounds ranged from 6.7 to 31.5 μM. Compounds 7 and 11 reduced the secretions of IFN-γ and IL-2 significantly. Further immunofluorescence experiments and a docking study with NF-κB P65 showed that compound 13 interfered with the proliferation of HaCaT cells by inhibiting the NF-κB P65 phosphorylation at the protein level. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
49. The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review.
- Author
-
Stepkowski, Stanislaw, Bekbolsynov, Dulat, Oenick, Jared, Brar, Surina, Mierzejewska, Beata, Rees, Michael A., and Ekwenna, Obi
- Subjects
REGULATORY T cells ,VACCINE effectiveness ,BOOSTER vaccines ,T cells ,B cells - Abstract
Since their conception with the smallpox vaccine, vaccines used worldwide have mitigated multiple pandemics, including the recent COVID-19 outbreak. Insightful studies have uncovered the complexities of different functional networks of CD4 T cells (T helper 1 (Th1); Th2, Th17) and CD8 T cells (T cytotoxic; Tc), as well as B cell (B
IgM , BIgG , BIgA and BIgE ) subsets, during the response to vaccination. Both T and B cell subsets form central, peripheral, and tissue-resident subsets during vaccination. It has also become apparent that each vaccination forms a network of T regulatory subsets, namely CD4+ CD25+ Foxp3+ T regulatory (Treg) cells and interleukin-10 (IL-10)-producing CD4+ Foxp3− T regulatory 1 (Tr1), as well as many others, which shape the quality/quantity of vaccine-specific IgM, IgG, and IgA antibody production. These components are especially critical for immunocompromised patients, such as older individuals and allograft recipients, as their vaccination may be ineffective or less effective. This review focuses on considering how the pre- and post-vaccination Treg/Tr1 levels influence the vaccination efficacy. Experimental and clinical work has revealed that Treg/Tr1 involvement evokes different immune mechanisms in diminishing vaccine-induced cellular/humoral responses. Alternative steps may be considered to improve the vaccination response, such as increasing the dose, changing the delivery route, and/or repeated booster doses of vaccines. Vaccination may be combined with anti-CD25 (IL-2Rα chain) or anti-programmed cell death protein 1 (PD-1) monoclonal antibodies (mAb) to decrease the Tregs and boost the T/B cell immune response. All of these data and strategies for immunizations are presented and discussed, aiming to improve the efficacy of vaccination in humans and especially in immunocompromised and older individuals, as well as organ transplant patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
50. Immunometabolic Regulation of Vaccine-Induced Antibody Responses in Aging Mice.
- Author
-
Frasca, Daniela, Romero, Maria, Padula, Laura, Fisher, Eva, and Strbo, Natasa
- Subjects
B cells ,METABOLIC reprogramming ,ANTIBODY formation ,COVID-19 vaccines ,VACCINE effectiveness - Abstract
Immune cells undergo metabolic reprogramming to meet the demands associated with immune responses. The effects of aging on these pathways and on the metabolic phenotype of the immune cells participating in antibody responses to vaccines are still largely unknown. Here we used a vaccine for SARS-CoV-2 that utilizes the cellular heat shock chaperone glycoprotein 96 (gp96), engineered to co-express SARS-CoV-2 Spike (spike) protein (gp96-Ig-S). Results show that this vaccine induces comparable B cell primary responses in young and old mice at later time points, but a significantly lesser secondary response in old as compared to young mice, with the antibodies generated in the secondary response being also of lower avidity. This occurs because aging changes the B cell metabolic phenotype and induces hyper-metabolic B cells that are associated with higher intrinsic inflammation and decreased protective antibody responses. However, the gp96-Ig-S vaccine was found to be effective in significantly reducing the metabolic/inflammatory status of B cells from old mice, suggesting the possibility that targeting metabolic pathways may improve immune function in old mice that do not respond adequately to the vaccine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.